Long Term Growth % Forecast Revision Date

Join now and get access to the full platform

Search for company or ETF

0 results available. Select is focused ,type to refine list, press Down to open the menu,

1.00

Price

–

Fair Value

–

Upside

0.98 - 7.79

52-week range

Create Chart Create Model Add To Watchlist

Analysis

Fiscal Years

Trailing Twelve Months

Fiscal Halfs

Fiscal Quarters

Daily

Hide this widget

The following section summarizes insights on 's Long Term Growth % Forecast Revision Date:

Inozyme Pharma Inc's long term growth % forecast revision date is Nov 14, '20 12:53 am, UTC

Benchmarks

Hide this widget

No data available

Metric Usage: Long Term Growth % Forecast Revision Date

Hide this widget

earnings_growth_lt_revision_date

Slug

date

Datatype

text

Format

current

Default Period

Periods Supported

Free

Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Long Term Growth % Forecast Revision Date in the growth category include:

Unadjusted EBIT CAGR (7y) - Seven-year compound annual growth rate in unadjusted EBIT.
Diluted EPS CAGR (10y) - Ten-year compound annual growth rate in diluted eps.
AFFO Forecast CAGR (3y) - Three year compound annual growth rate in forecasted adjusted funds from operations (AFFO).
AFFO Forecast CAGR (2y) - Two year compound annual growth rate in forecasted adjusted funds from operations (AFFO).

View Full List

Search for metric or datapoint

Long Term Growth % Forecast Revision Date

The date/time at which the current consensus estimate of forecasted long term growth was last updated.

Definition of Long Term Growth % Forecast Revision Date

Hide this widget

The date/time at which the current consensus estimate of forecasted long term growth was last updated.

Sector Benchmark Analysis

Sector

Industry Group

Industry

Hide this widget

No data available